CombiMatrix Partnership Creates Prototype Tool for Nanoparticles; Combi Shares Close Up 10.4 Percent on News | GenomeWeb

NEW YORK, Dec. 15 (GenomeWeb News) - CombiMatrix and partner Nanomaterials Discovery Corporation have created a prototype workstation for the combinatorial discovery and development of new nanomaterials, the firms said today.

The news, which is considered a milestone by the partners, caused shares in CombiMatrix yesterday to close up 10.35 percent at $4.05 in unusually heavy volume.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: genetic target for urothelial bladder cancer treatment, and more.

At the Conversation, the University of Oxford's Michael Macklay writes that learning genetic risk of disease is a personal decision.

Two dozen scientific organizations have endorsed the March for Science, according to ScienceInsider.

Researchers in Japan describe a chimpanzee with a chromosomal abnormality similar to human Down syndrome, Mashable reports.